US advances plan to allow specialty pharmacies to produce peptides favored by RFK Jr.

U.S. health officials are advancing a regulatory plan to permit specialty pharmacies to compound certain peptides, a largely unregulated class of injections championed by HHS Secretary Robert F. Kennedy Jr. The move signals a policy shift toward broader access to these products, but raises safety and oversight concerns given limited clinical evidence. The final scope and implementation timeline remain uncertain.